Oramed Failure Highlights Insurmountable Challenge Of Oral Insulin Delivery

Israeli Firm's Candidate Suffers Phase III Flop

 
• By Kevin Grogan

Oramed's attempts to advance an oral formulation of insulin for type 2 diabetes patients have been scuppered with a Phase III fail that has sunk the stock.

Insulin wireframe of syringe and vial
Attempts to replace injections of insulin with a more convenient delivery method have failed miserably • Source: Shutterstock

More from Alimentary/Metabolic

More from Therapy Areas